Supernus Pharmaceuticals (SUPN) Surpasses Q2 Earnings and Revenue Estimates

Supernus Pharmaceuticals (SUPN) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +93.62%. A quarter ago, it was expected that this drugmaker would post earnings of $0.38 per share when it actually produced earnings of $0.42, delivering a surprise of +10.53%.Over the last four quarters, ...